Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial

被引：0
|
作者：
Shinya Fujiki
Atsushi Tanaka
Takumi Imai
Michio Shimabukuro
Hiroki Uehara
Ikuko Nakamura
Kazuo Matsunaga
Makoto Suzuki
Takeshi Kashimura
Tohru Minamino
Takayuki Inomata
Koichi Node
机构：
[1] Niigata University Graduate School of Medical and Dental Sciences,Department of Cardiovascular Medicine
[2] Saga University,Department of Cardiovascular Medicine
[3] Osaka City University Graduate School of Medicine,Department of Medical Statistics
[4] Fukushima Medical University,Department of Diabetes, Endocrinology, and Metabolism
[5] Urasoe General Hospital,Division of Cardiology
[6] Saga-Ken Medical Centre Koseikan,Department of Cardiovascular Medicine
[7] Imari-Arita Kyoritsu Hospital,Department of Internal Medicine
[8] Yokohama Minami Kyosai Hospital,Department of Cardiology
[9] Juntendo University Graduate School of Medicine,Department of Cardiovascular Biology and Medicine
来源：
Clinical Research in Cardiology | 2023年 / 112卷
关键词：
Sodium–glucose cotransporter-2 (SGLT2) inhibitor; Canagliflozin; Estimated plasma volume (ePV); Estimated extracellular volume (eEV); Estimated glomerular filtration rate (eGFR); HFpEF; HFrEF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 97
页数：10
相关论文
共 50 条
  • [21] Effectiveness and Safety of Sodium-Glucose Cotransporter-2 Inhibitor Continuation in Patients With Type 2 Diabetes and Late-Stage Chronic Kidney Disease
    Denny, Olivia
    Albanese, Nicole P.
    Meaney, Calvin J.
    Siwarski, Nicole E.
    Monte, Scott V.
    JOURNAL OF PHARMACY TECHNOLOGY, 2025, 41 (02) : 65 - 71
  • [22] Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
    Cheema, Huzaifa Ahmad
    Shafiee, Arman
    Athar, Mohammad Mobin Teymouri
    Rafiei, Mohammad Ali
    Mehmannavaz, Atefe
    Jafarabady, Kyana
    Shahid, Abia
    Ahmad, Adeel
    Ijaz, Sardar Hassan
    Dani, Sourbha S.
    Minhas, Abdul Mannan Khan
    Nashwan, Abdulqadir J.
    Fudim, Marat
    Fonarow, Gregg C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [23] Selective sodium-glucose cotransporter-2 inhibitors in the improvement of hemoglobin and hematocrit in patients with type 2 diabetes mellitus: a network meta-analysis
    Luo, Yuanyuan
    Bai, Ruojing
    Zhang, Wei
    Qin, Guijun
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [24] Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease An Updated Meta-Analysis of Randomized Controlled Trials
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Goldberg, Michael
    Jain, Diwakar
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2020, 28 (03) : 116 - 124
  • [25] Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction
    Wood, Nathanael
    Straw, Sam
    Cheng, Chew W.
    Hirata, Yu
    Pereira, Marcelo G.
    Gallagher, Harrison
    Egginton, Stuart
    Ogawa, Wataru
    Wheatcroft, Stephen B.
    Witte, Klaus K.
    Roberts, Lee D.
    Bowen, T. Scott
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 925 - 935
  • [26] Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial
    Romiti, Giulio Francesco
    Nabrdalik, Katarzyna
    Corica, Bernadette
    Bucci, Tommaso
    Proietti, Marco
    Qian, Min
    Chen, Yineng
    Thompson, John L. P.
    Homma, Shunichi
    Lip, Gregory Y. H.
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (04) : 931 - 939
  • [27] Suppression of Cardiogenic Edema with Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction: Mechanisms and Insights from Pre-Clinical Studies
    Sullivan, Ryan D.
    McCune, Mariana E.
    Hernandez, Michelle
    Reed, Guy L.
    Gladysheva, Inna P.
    BIOMEDICINES, 2022, 10 (08)
  • [28] Sodium-Glucose Cotransporter-2 Inhibitors and Diabetic-Ketoacidosis in T2DM Patients: An Updated Meta-Analysis and a Mendelian Randomization Analysis
    Wang, Yufei
    Qin, Yuhan
    Zhang, Jing
    Wu, Anhu
    Qin, Xiaohan
    Du, Le
    Zhang, Huabing
    Guo, Xiaoxiao
    Zhang, Shuyang
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [29] Effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on serum uric acid levels in patients with chronic kidney disease: a systematic review and network meta-analysis
    Zhang, Linli
    Zhang, Fan
    Bai, Yan
    Huang, Liuyan
    Zhong, Yifei
    Zhang, Xianwen
    BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (01)
  • [30] Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone and renin levels in diabetes mellitus type 2 patients: a systematic review and meta-analysis
    Manosroi, Worapaka
    Danpanichkul, Pojsakorn
    Atthakomol, Pichitchai
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345